Lymphomas

Most recent

Investigator Commentary on the MAINTAIN study by Dr. Mathias Rummel

At the 2017 ASH Annual Meeting, New Evidence spoke with Dr. Mathias Rummel, Head of the Department of Hematology at the Clinic for Hematology and Medical Oncology at the Justus-Liebig University Hospital, Giessen, Germany, about the results of the MAINTAIN study...

Other

Twitter feed

Local #radiotherapy improves OS in metastatic #prostatecancer with low disease burden. #ESMO18 https://t.co/RCbjG89hYS
h J R
#Immunotherapy as first-line treatment in some metastatic #colorectal #cancers? #ESMO18 https://t.co/Pl4prgsFo0
h J R
Genetic marker of #pancreaticcancer may predict #radiation therapy outcomes. https://t.co/RIjInoqOmD
h J R
A shortcut to #cancer drug development: live tumour testing. https://t.co/dYZmtRqMhX
h J R
New #cancer #vaccine shows early promise for patients with #HER2-positive cancers. https://t.co/kjLaFxdsbJ
h J R